Search research articles
Contact Us
Filters
Showing results (291-300 of 418) with videos related to
Page
of 42
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 21, 2023
Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers
Lucile Vanhersecke, Antoine Bougouin, Amandine Crombé, et al.
JTO Clinical and Research Reports
|
October 1, 2025
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5
Anas Gazzah, Charles Ricordel, Antoine Italiano, et al.
Cancer Immunology, Immunotherapy : CII
|
July 3, 2021
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
Antoine Italiano, Philippe A Cassier, Chia-Chi Lin, et al.
Advances in Therapy
|
October 17, 2018
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours
Ruth Plummer, Henk M Verheul, Filip Y F L De Vos, et al.
BMJ Open
|
June 21, 2019
ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol
Aude Lacourt, Brice Amadéo, Céline Gramond, et al.
Molecular Cancer
|
September 13, 2024
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics
Sophie Cousin, Jean-Philippe Guégan, Kohei Shitara, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 26, 2023
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
Jérôme Cartry, Sabrina Bedja, Alice Boilève, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2017
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
Nicolas Penel, Axel Le Cesne, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2020
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Nicolas Penel, Olivier Mir, Jennifer Wallet, et al.
Plos One
|
October 11, 2018
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
Paul H Cottu, Jacques Bonneterre, Andrea Varga, et al.
Page
of 42
Search research articles
Search
Showing results (291-300 of 418) with videos related to
Sort By:
Page
of 42
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
February 21, 2023
Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers
Lucile Vanhersecke, Antoine Bougouin, Amandine Crombé, et al.
JTO Clinical and Research Reports
|
October 1, 2025
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5
Anas Gazzah, Charles Ricordel, Antoine Italiano, et al.
Cancer Immunology, Immunotherapy : CII
|
July 3, 2021
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
Antoine Italiano, Philippe A Cassier, Chia-Chi Lin, et al.
Advances in Therapy
|
October 17, 2018
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours
Ruth Plummer, Henk M Verheul, Filip Y F L De Vos, et al.
BMJ Open
|
June 21, 2019
ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol
Aude Lacourt, Brice Amadéo, Céline Gramond, et al.
Molecular Cancer
|
September 13, 2024
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics
Sophie Cousin, Jean-Philippe Guégan, Kohei Shitara, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 26, 2023
Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer
Jérôme Cartry, Sabrina Bedja, Alice Boilève, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2017
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group
Nicolas Penel, Axel Le Cesne, Sylvie Bonvalot, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2020
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Nicolas Penel, Olivier Mir, Jennifer Wallet, et al.
Plos One
|
October 11, 2018
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
Paul H Cottu, Jacques Bonneterre, Andrea Varga, et al.
Page
of 42